52 min listen
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
ratings:
Length:
61 minutes
Released:
Sep 13, 2023
Format:
Podcast episode
Description
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NHL)
CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NHL)
Released:
Sep 13, 2023
Format:
Podcast episode
Titles in the series (100)
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition: Featuring a discussion of recent data with induction and maintenance therapy for acute myeloid leukemia with Jeffrey E Lancet, MD moderated by Neil Love, MD. by Oncology Today with Dr Neil Love